News

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Goldman Sachs GS has been a leader of the pack. May 12 saw a strong gap up of over 4% that gave the stock some distance above ...
High R&D Expenses & Rising Debt Levels Ail Toyota (TM) Per the Zacks analyst, high R&D expenses on advanced technologies and alternative fuels are likely to limit Toyota's near-term margins. Rising ...
Dutch Bros Inc. (NYSE:BROS) ranks among the best cyclical stocks to buy now. On June 26, Goldman Sachs began coverage of ...
Wall Street's smartest money has quietly amassed over $150 million in bullish positions, with Goldman Sachs eliminating all ...
As global tensions rise and battlefields go unmanned, defense tech is the new arms race. Drones are now mission-critical — ...
Live Updates Live Coverage Has Ended Weekly Wrap-up 2:54 pm The Vanguard S&P 500 ETF closed along with the rest of the market ...
Amplify CWP International Enhanced Dividend Income ETF offers a diversified, actively managed portfolio. Read why IDVO ETF is ...
The payments company is working with advisers to identify smaller international peers to acquire as part of efforts to expand ahead of a bumper stock market listing, Sky News learns.
Fundraising from initial public offerings in London has tumbled to its lowest level in at least 30 years, in a stark sign of ...
Customers at a T.J. Maxx store in Chicago. Goldman Sachs economists project higher goods inflation ahead. (Scott Olson/Getty Images) Price increases have cooled off so far this year, but Goldman ...
VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.